Back
Intuit, Inc. Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Buy
58
INTU
Intuit, Inc.
Last Price:
$662.26
Seasonality Move:
1.71%
Buy
60
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$30.66
Seasonality Move:
-6.94%
Buy
58
Intuit, Inc. (INTU)
is a Buy
Is Intuit, Inc. a Buy, Sell or Hold?
-
The current Intuit, Inc. [INTU] share price is $655.75. The Score for INTU is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
INTU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $26.58. The Score for OLMA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INTU Stock Price Chart
What is Intuit, Inc.'s stock price today?
-
The Intuit, Inc. share price today is $655.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INTU is experiencing slight buying pressure.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $26.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
INTU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 50.81 | Buy |
| Chaikin Money Flow: | 35008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.6 | Buy |
| Relative Strength Index (14 RSI): | 74.25 | Buy |
| Chaikin Money Flow: | -585363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
INTU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 649.71 | Buy |
| 20-day SMA: | 650.06 | Buy |
| 50-day SMA: | 658.66 | Sell |
| 200-day SMA: | 676.96 | Sell |
| 8-day EMA: | 653.84 | Buy |
| 20-day EMA: | 652.5 | Buy |
| 50-day EMA: | 660.81 | Sell |
| 200-day EMA: | 671.01 | Sell |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.51 | Sell |
| 20-day SMA: | 21.26 | Buy |
| 50-day SMA: | 14.13 | Buy |
| 200-day SMA: | 7.33 | Buy |
| 8-day EMA: | 26.63 | Sell |
| 20-day EMA: | 22.44 | Buy |
| 50-day EMA: | 16.3 | Buy |
| 200-day EMA: | 9.75 | Buy |
Intuit, Inc. Earnings Growth & INTU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.79 per share, an increase next quarter of $0.42 per share, an increase this year of $3.26 per share, and an increase next year of $3.10 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and a decrease next year of $0.48 per share.
Intuit, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||